This finding may be highly significant since NLRP3 has been suggested as a cerebrospinal fluid (CSF) biomarker in TBI patients with poor prognosis (Wallisch et al., 2017).
← all excerpts
The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury.
1
—
—